Dr Reddy's Laboratories Ltd (RDY) reports a robust 16% YoY revenue growth, driven by strategic product launches and market ...

Dr. Reddy's Laboratories Ltd. 500124 shares slid 5.01% to 1,224.70 Indian rupees Friday, on what proved to be an all-around ...

The generic drugmaker was the top loser on the Nifty Pharma index and the benchmark Nifty 50 index. "The drop in shares comes ...

Shares of Dr Reddy's Laboratories fell by 5% as the company's third-quarter profit rise failed to impress investors. The ...

Dr Reddy’s Laboratories on Thursday said its consolidated net profit increased 2 per cent to Rs 1,413 crore in the third ...

Dr Reddy’s Laboratories share price declined more than 6% in the morning trades on Friday post Q3 results that were announced after the market hours of Thursday ...

Prabhudas Lilladher recommended reduce rating on Dr. Reddy's Laboratories with a target price of Rs 1335 in its research ...

Dr. Reddy’s Laboratories Ltd ( ($RDY) ) has released its Q3 earnings. Here is a breakdown of the information Dr. Reddy’s ...

Welcome to the Dr Reddys Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

The company's North American revenue has seen a decline of over 9%. One of the primary worries is the reduction in revenues ...

Most pharma stocks traded in the red during Friday’s session, with the Nifty Pharma index falling 2.19% at 21,854.15. Dr.

Jefferies said that Dr Reddy's weakness in core profitability showed up in the Q3 numbers. The company also faced incremental ...